Array CGH in brain tumors

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Alterations in the copy number of the cancer genome are frequently observed in brain tumors especially gliomas. Some pertinent examples include amplification of the EGFR locus in chromosome 7p and loss of the PTEN locus in 10q in glioblastoma. Meningiomas are often associated with loss of the NF2 locus in 22q. Array CGH or aCGH probes provide a reliable, consistent, and economical method of profiling genome-wide copy number alterations (CNAs) of cancer specimens at fairly robust resolution. This has allowed for the systematic assessment of brain tumors for recurrent genomic CNAs. In addition, recent technical advancements have increased the robustness of this technique to accommodate DNA derived from formalin-fixed paraffin-embedded (FFPE) tissue. Lastly, novel technologies such as next-generation sequencing and multiplex digital gene counting technology such as NanoString will expand the repertoire of techniques for assessing CNAs in brain tumors. © Springer Science+Business Media, LLC 2013.

Cite

CITATION STYLE

APA

Mohapatra, G., Sharma, J., & Yip, S. (2013). Array CGH in brain tumors. Methods in Molecular Biology, 973, 325–338. https://doi.org/10.1007/978-1-62703-281-0_20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free